vapenovaco.com – FDA Warning Letter, May 1, 2026

On May 19, 2026, the FDA issued a warning letter to vapenovaco.com after a review of their website revealed the unauthorized sale of dissolvable tobacco products. The company, based in New York, was found to be distributing "Spearmint Jolt Nicotine Strips 2mg" to customers in the United States without the necessary legal permissions.

Under the Federal Food, Drug, and Cosmetic (FD&C) Act, any new tobacco product—defined as those not marketed before February 15, 2007—must receive a premarket authorization order from the FDA before it can be legally sold. Because vapenovaco.com failed to obtain this authorization or provide required product information, the FDA classified the nicotine strips as both adulterated and misbranded. A significant concern cited by the agency is that these products closely resemble common breath strips, making them highly attractive to children and easy for youth to conceal from adults. Such products pose a severe risk of acute nicotine poisoning in young children.

The FDA has directed the company to immediately cease the sale and distribution of these unauthorized products. Vapenovaco.com must submit a written response within 15 working days detailing their corrective actions and a plan for maintaining future compliance. Failure to address these violations promptly may result in regulatory enforcement, including financial penalties, product seizures, or legal injunctions.